Chinese biotech says it will start first in vivo beta-thalassemia trial

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Good morning. I’m still recovering from yesterday, when Chicago was reportedly colder than Antarctica. I hope you’re all staying warm wherever you are. Let’s get into the news today.

Read the rest…

Market News and Data brought to you by Benzinga APIs

To add Benzinga News as your preferred source on Google, click here.